"10.1371_journal.pone.0146076","plos one","2016-01-08T00:00:00Z","Karen Louise Thomsen; Jane Macnaughtan; Giovanni Tritto; Rajeshwar P Mookerjee; Rajiv Jalan","Liver Failure Group, UCL Institute for Liver and Digestive Health, University College London Medical School, London, United Kingdom","Conceived and designed the experiments: RJ. Performed the experiments: JM GT. Analyzed the data: KLT RJ. Contributed reagents/materials/analysis tools: JM GT. Wrote the paper: KLT RJ RM.","Rajiv Jalan received research funding from Vital Therapies, has served on Scientific Advisory Board for Conatus Pharma, and received lecture fees from Gambro and has on-going research collaboration with Gambro, Grifols and is the Principal Investigator of an Industry sponsored study (Sequana Medical). He is also inventor for a drug, L-ornithine phenyl acetate which UCL has licensed to Ocera Therapeutics. He is also the founder of UCL spin-out company Yaqrit ltd. and Cyberliver ltd. All other authors have nothing to disclose. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","01","Karen Louise Thomsen","KLT",5,TRUE,1,2,2,3,TRUE,TRUE,FALSE,0,NA,FALSE
